country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-189711

Copy Link Print Information

MTP-B1

MTP-B1 is a POLRMT MtPTAC degrader that activates mitochondrial ClpP. MTP-B1 recruits ClpP as a protease module to POLRMT, inducing ClpP-dependent proteolysis and reducing POLRMT protein levels. MTP-B1 induces ROS and apoptosis. MTP-B1 inhibits proliferation, clonogenic growth, oxidative phosphorylation pathway gene expression, and mitochondrial transcription. MTP-B1 inhibits tumor growth in xenograft tumor mouse models and reduces tumor Ki67. MTP-B1 can be used for pancreatic cancer research (pink: POLRMT inhibitor: HY-181072; blue: small molecule that activates mitochondrial protease ClpP: HY-189815.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

分子式: C₅₂H₅₁F₄N₇O₇
分子量:962.00

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

MTP-B1 構造式

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- Cellular Effect
- 体外実験
- Parmacokinetics
- 体内実験
化学情報
純度とドキュメンテーション
参考文献
Calculators
Help & FAQs
関連分類
Bioz

生物活性

製品説明

PROTACs アイソフォーム固有の製品をすべて表示 :

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
MIA PaCa-2	DC₅₀	187.2 nM	Half-maximal degradation of POLRMT in human MIA PaCa-2 pancreatic cancer cells after 24 hrs incubation by Western blot. Half-maximal degradation of POLRMT in human MIA PaCa-2 pancreatic cancer cells after 24 hrs incubation by Western blot.	42819300
ASPC1	DC₅₀	416.9 nM	Half-maximal degradation of POLRMT in human AsPC-1 pancreatic cancer cells. Half-maximal degradation of POLRMT in human AsPC-1 pancreatic cancer cells.	42819300
MIA PaCa-2	IC50	5.08 nM	Antiproliferative activity against human MIA PaCa-2 pancreatic cancer cells by SRB assay. Antiproliferative activity against human MIA PaCa-2 pancreatic cancer cells by SRB assay.	42819300
ASPC1	IC50	57.76 nM	Antiproliferative activity against human AsPC-1 pancreatic cancer cells by SRB assay. Antiproliferative activity against human AsPC-1 pancreatic cancer cells by SRB assay.	42819300
MIA PaCa-2	DC₅₀	8.81 nM	Half-maximal degradation of POLRMT in human MIA PaCa-2 pancreatic cancer cells after 7 days incubation. Half-maximal degradation of POLRMT in human MIA PaCa-2 pancreatic cancer cells after 7 days incubation.	42819300
MIA PaCa-2	IC50	6.32 nM	Antiproliferative activity against human MIA PaCa-2 pancreatic cancer cells expressing negative control by SRB assay. Antiproliferative activity against human MIA PaCa-2 pancreatic cancer cells expressing negative control by SRB assay.	42819300
MIA PaCa-2	IC50	94.15 nM	Antiproliferative activity against human MIA PaCa-2 pancreatic cancer cells overexpressing POLRMT by SRB assay. Antiproliferative activity against human MIA PaCa-2 pancreatic cancer cells overexpressing POLRMT by SRB assay.	42819300

体外実験

Anti-cancerProtein/Amino Acid MetabolismMitochondrial Oxidative PhosphorylationOxidative StressMitochondrial FunctionApoptosisOthers

Anti-cancer

MTP-B1 (0.5-5 μM and 125-5000 nM; 24 h) potently degrades POLRMT in MIA PaCa-2 cells with a DC₅₀ of 187.2 nM and a D_max of 98.18%; in AsPC-1 cells, the DC₅₀ is 416.9 nM^[1].
MTP-B1 (1 μM; 0-48 h) rapidly degrades POLRMT in MIA PaCa-2 cells, and the degradation persists after compound washout^[1].
MTP-B1 (0.1-1 μM) reduces POLRMT immunofluorescence in MIA PaCa-2 cells in a dose-dependent manner^[1].

Anti-cancer

Protein/Amino Acid Metabolism

MTP-B1 (7 days) exhibits potent antiproliferative activity against MIA PaCa-2 and AsPC-1 cells with IC₅₀ values of 5.08 and 57.76 nM, respectively, and degrades POLRMT with a DC₅₀ of 8.81 nM^[1].

Mitochondrial Oxidative Phosphorylation

MTP-B1 broadly inhibits OXPHOS gene expression and mitochondrial transcription^[1].

Oxidative Stress

Mitochondrial Function

Anti-cancer

Apoptosis

MTP-B1 (1-500 nM) inhibits clonogenic growth of MIA PaCa-2 cells and induces ROS and apoptosis without affecting cell cycle progression or mitochondrial membrane potential^[1].

Others

MTP-B1 (1 μM)-induced POLRMT degradation requires simultaneous binding to both POLRMT and ClpP, and is independent of CRL-dependent ubiquitination and the autophagy-lysosomal pathway^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

MIA PaCa-2 cells
Concentration:

0.5, 1, 5 μM
Incubation Time:

24 h
Result:

Retained potent POLRMT degradation activity in the initial screen;

Western Blot Analysis^[1]

Cell Line:

MIA PaCa-2 and AsPC-1 cells
Concentration:

125, 250, 500, 1000, 5000 nM
Incubation Time:

24 h
Result:

Dose-response assays gave a DC₅₀ of 187.2 nM and Dmax of 98.18% in MIA PaCa-2 cells.
Showed a DC₅₀ of 416.9 nM in AsPC-1 cells.

Western Blot Analysis^[1]

Cell Line:

MIA PaCa-2 cells
Concentration:

1 μM (time-course); 1 μM for 24 h followed by washout
Incubation Time:

0, 4, 8, 16, 24 h; washout 24 h; 48 h
Result:

MTP-B1 induced more than 50% POLRMT degradation within 16 h and near-complete degradation by 24 h.
A lower-molecular-weight POLRMT species appeared with degradation.
After washout, no appreciable POLRMT recovery was detected within 24 h, with only partial restoration at 48 h.

Parmacokinetics

Species	Dose	Route	C_max	AUC_0-∞	T_1/2
Mice^[1]	50 mg/kg	i.v.	61966.67 ng/mL	26,100.84 ng·h/mL	3.47 h

体内実験

Anti-cancer

MTP-B1 (25-100 mg/kg; i.v.; every other day; 25 days) inhibits tumor growth in the MIA PaCa-2 xenograft mice tumor model^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

mice with MIA PaCa-2 xenograft^[1]
Dosage:

25, 50, 100 mg/kg
Administration:

i.v.; every other day; 25 days
Result:

Achieved a tumor growth inhibition (TGI) of 70.1% at 100 mg/kg.
No significant body weight
loss.
Exhibited POLRMT degradation, reduced the
proliferation marker Ki67 and significant increased
TUNEL-positive apoptotic cells in tumors.

Related Protocols :

化学情報

分子量 962.00
分子式 C₅₂H₅₁F₄N₇O₇
SMILES

O=C(NCCCN(C1=C(CN(CC2=CC=CC(C#N)=C2)CC1)C(N3CC4=CC=C(C(F)(F)F)C=C4)=O)C3=O)CCN5CCN(C([C@H](OC6=CC(O7)=C(C=C6F)C(C8=CC=CC=C8C)=CC7=O)C)=O)CC5
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Chen C, et al. Development of High-Efficiency Mitochondrial Protease Targeting Chimeras (MtPTACs) for Targeted Degradation of POLRMT and Beyond. JACS Au. 2026 Sep 9;6(9):5439-5454. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ

Amount: USD 0.00

生物活性
- 製品説明
- 体外実験
- 体内実験
化学情報
純度とドキュメンテーション
参考文献

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

MTP-B1

PROTACs アイソフォーム固有の製品をすべて表示

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示

生物活性

製品説明

Cellular Effect

体外実験

Parmacokinetics

体内実験

化学情報

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

MTP-B1 関連分類

HY-189711 関連分類

Bioz

Keywords

最近チェックした製品